THR-β agonist 3
Modify Date: 2024-01-12 14:34:37
THR-β agonist 3 structure
|
Common Name | THR-β agonist 3 | ||
|---|---|---|---|---|
| CAS Number | 2656400-84-7 | Molecular Weight | 526.99 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H32ClO5P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of THR-β agonist 3THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1]. |
| Name | THR-β agonist 3 |
|---|
| Description | THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Li Peng, et al. Benzo-fused ring compounds. Patent WO2021129827A1. |
| Molecular Formula | C29H32ClO5P |
|---|---|
| Molecular Weight | 526.99 |